Oncology has experienced progress at breakneck speed, with recent discoveries leading to the development of new drugs that have revolutionised cancer treatment. The clinical use of genomic data and the large production of data has truly brought upon us an era of precision medicine and has levered progress in fundamental, translational and clinical research. The conclusion is evident: it is no longer possible to practice medicine without taking multidisciplinary and translational medicine into account.
The Congress will cover the most recent scientific advances, demonstrating how fundamental and translational science have become essential to the success of clinical oncologists. The aim is to promote interaction between researchers and clinical oncologists so the decisions are even more accurate. Given the theme relevance for Clinical Oncology, the event will also include a pre-course entitled ‘Molecular Biology for Clinical Oncologists: What do we have to know?’, so that clinical oncologists and health professional comprehend and interact with the tools of basic science even more safely.
SBOC-AACR Joint Congress:
A Translational Approach to Clinical Oncology